NCT01090154View on ClinicalTrials.gov

Study of Cimzia for the Treatment of Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 1, 2010

Primary Completion Date

December 10, 2021

Study Completion Date

December 10, 2021

Conditions
Ulcerative Colitis
Interventions
DRUG

Cimzia

Cimzia 400mg administered via two 200mg subcutaneous injections at weeks 0, 2, and 4; followed by every 4 week dosing.

Trial Locations (2)

19104

University of Pennsylvania, Philadelphia

98195

University of Washington, Seattle

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

collaborator

University of Pennsylvania

OTHER

lead

University of Washington

OTHER